Immucell Corp (ICCC) Reports Q1 EPS of $0.21

Immucell Corp (NASDAQ: ICCC) reported Q1 EPS of $0.21. Revenue for the quarter came in at $10.36 million, versus $0 reported last year.

For earnings history and earnings-related data on Immucell Corp (ICCC) click here.

You May Also Be Interested In

• FedEx falls 4% as FY2027 profit forecast misses expectations despite Q4 beat
• BioNxt closes $2M private placement at $0.33 per unit
• Gates Industrial launches three new bicycle belt drive sprocket families